# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: K051472   
B. Purpose for Submission: This a bundled submission for the clearance of 5 devices   
C. Measurand: Low Molecular Weight Heparin (LMWH) Unfractionated Heparin (UF)   
D. Type of Test: Quality Control Material   
E. Applicant: Hyphen BioMed F. Proprietary and Established Names: Biophen Low Molecular Weight Heparin (LMWH) Control Plasma Biophen Low Molecular Weight Heparin (LMWH) Control Plasma Low Biophen Unfractionated Heparin (UFH) Control Plasma Biophen Heparin Calibrator, Biophen Unfractionated (UFH) Calibrator

# G. Regulatory Information:

1. Regulation section:

21 CFR 864.5425   
21 CFR 864.7525

2. Classification:

Class II

3. Product code:

GGN, GGC, KFF

4. Panel:

81 Hematology

# H. Intended Use:

1. Intended use(s):

The Biophen LMWH Control Kit is a set of control plasmas for the quality control of Low Molecular Weight Heparin (LMWH) measurements, using anti-Xa colorimetric assays.

The Biophen LMWH Control Low Kit is a set of control plasmas for the quality control of Low Molecular Weight Heparin (LMWH) measurements, using anti-Xa colorimetric assays.

The Biophen UFH Control Kit is a set of control plasmas for the quality control of Low Molecular Weight Heparin (LMWH) measurements, using anti-Xa colorimetric assays.

The Biophen UFH Calibrator is a set of calibration plasmas for Unfractionated Heparin (UFH) measurements, using anti-Xa colorimetric assays.

The Biophen Heparin Calibrator is a set of calibration plasmas for Heparin (UFH and LMWH) measurements, using anti-Xa colorimetric assays.

2. Indication(s) for use: Same as Intended Use

3. Special conditions for use statement(s): Not applicable

4. Special instrument requirements: Not applicable

# I. Device Description:

Biophen UFH Control Plasma - $- 1 2 \mathrm { - } 1 \ \mathrm { m L }$ vials of human plasma supplemented at 2 different concentrations of unfractionated heparin (6 vials at each concentration)

Biophen LMWH Control Plasma $- 1 2 \mathrm { - } 1 \ \mathrm { m L }$ vials of human plasma supplemented at 2 different concentrations of low molecular weight heparin (6 vials at each concentration)

Biophen LMWH Control Plasma Low $- 1 2 \mathrm { - } 1 \ \mathrm { m L }$ vials of human plasma supplemented at 2 different concentrations of low molecular weight heparin (6 vials at each concentration)

Biophen UFH Calibrator - 20 vials (4 sets of 5 vials) $- 1 \mathrm { m L }$ vials of human plasma supplemented with different concentrations of unfractionated heparin (4 vials at each concentration)

Biophen Heparin Calibrator- 20 vials (4 sets of 5 vials) $- 1 \mathrm { m L }$ vials of human plasma supplemented with different concentrations of unfractionated heparin (4 vials at each concentration)

# J. Substantial Equivalence Information:

1. Predicate device name(s):

Instrumentation Laboratories Control Plasma LMW Heparin American Bioproducts Heparin Control Instrumentation Laboratories Calibration Plasma LMW Heparin Dade Behring Heparin Calibrators and Controls.

2. Predicate 510(k) number(s): K030965, K943520, K030964, K042941

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Not applicable

L. Test Principle: Not applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Intra-assay%CV</td></tr><tr><td rowspan=1 colspan=1>Biophen LMWH Control Level 3</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>Biophen LMWH Control Level 4</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1>Biophen LMWH Control Low Level1</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>BiophenLMWH Control Low Level 2</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>BiophenUFH Control Level 1</td><td rowspan=1 colspan=1>1.1</td></tr><tr><td rowspan=1 colspan=1>Biophen UFH Control Level 2</td><td rowspan=1 colspan=1>0.7</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Intra-assay%CV</td></tr><tr><td rowspan=1 colspan=1>Biophen UFH Calibrator Cal 1</td><td rowspan=1 colspan=1>na</td></tr><tr><td rowspan=1 colspan=1>BiophenUFHCalibratorCal 2</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=1>BiophenUFHCalibratorCal 3</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>BiophenUFHCalibratorCal 4</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>Biophen UFH Calibrator Cal 5</td><td rowspan=1 colspan=1>0.5</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Intra-assay%CV</td></tr><tr><td rowspan=1 colspan=1>Biophen Heparin Calibrator Cal 1</td><td rowspan=1 colspan=1>na</td></tr><tr><td rowspan=1 colspan=1>BiophenHeparinCalibratorCal 2</td><td rowspan=1 colspan=1>2.3</td></tr><tr><td rowspan=1 colspan=1>BiophenHeparinCalibratorCal 3</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>BiophenHeparinCalibratorCal 4</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>Biophen HeparinCalibrator Cal 5</td><td rowspan=1 colspan=1>0.5</td></tr></table>

# b. Linearity/assay reportable range:

Not applicable

c. Traceability, Stability, Expected values (controls, calibrators, or methods): International Standard for protein for LMWH (NIBSC) (Code 85/600) $5 ^ { \mathrm { t h } }$ International Standard for UFH (NIBSC) (Code 97/578)

d. Detection limit

e. Analytical specificity:

f. Assay cut-off:

2. Comparison studies: Not applicable

a. Method comparison with predicate device:

b. Matrix comparison:

3. Clinical studies: Not applicable

a. Clinical Sensitivity:

b. Clinical specificity:

c. Other clinical supportive data (when a. and b. are not applicable):

4. Clinical cut-off: Not applicable

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision, based on a Tier 1 review.